Income statement
USD
Annual
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 |
| Operating Income | -129K | -84K | -382K | -20K |
| EBITDA | -129K | 0 | 0 | 10K |
| Net Income | -129K | -84K | -382K | -20K |
| EPS (Diluted) | — | — | — | — |
Technology
Live Price
Offline$0.0055
+0.00% today
Window Change
-97.39%
Window
Jun 23, 2025 → May 15, 2026
Coverage: 224 bars · Jun 23, 2025 → May 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Ulixe Corp. (ULIX) is a Technology stock with listed on OTC. The stock last traded around $0.01 and down 97.4% across the available one-year price window (Jun 23, 2025 → May 15, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -25.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -25.0%, free cash flow +44.3% with operating margin 0.0% and ROIC -15.0%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ULIX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ULIX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ULIX Max Drawdown
-98.70%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ULIX and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$20.2K
+94.7% YoY
Free Cash Flow
-$27.7K
+95.1% YoY
Revenue Growth
+0.0%
EPS Growth
-25.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 |
| Operating Income | -129K | -84K | -382K | -20K |
| EBITDA | -129K | 0 | 0 | 10K |
| Net Income | -129K | -84K | -382K | -20K |
| EPS (Diluted) | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Cash & Equivalents | 39 | 16 | 13K | 17K |
| Total Assets | 237K | 215K | 346K | 356K |
| Total Liabilities | 81K | 35K | 139K | 332K |
| Shareholder Equity | 156K | 180K | 207K | 25K |
| Total Debt | 0 | 0 | 250K | 250K |
| Net Debt | -39 | -16 | 237K | 233K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
276K
+149.8% YoY
Capital Expenditures
304K
-2065.4% YoY
Free Cash Flow
28K
+95.1% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-14.5%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.